Rossari Biotech Q2 FY26 consolidated PAT increases to Rs. 36.87 Cr

Rossari Biotech Q2 FY26 consolidated PAT increases to Rs. 36.87 Cr

By: ICN Bureau

Last updated : October 16, 2025 8:14 am



Rossari Biotech has posted net profit of Rs. 70.47 crores for the 6 months period ended September 30, 2025


Rossari Biotech Limited has reported consolidated financial results for the period ended September 30, 2025.

Rossari Biotech has posted net profit of Rs. 36.87 crore for the period ended September 30, 2025 as against net profit of Rs. 33.59 crores for the period ended June 30, 2025. The company posted net profit of Rs.35.33 crore for the period ended September 30, 2024.

Rossari Biotech has reported total income of Rs. 587.71 crore during the period ended September 30, 2025 as compared to Rs. 544.91 crore during the period ended June 30, 2025. The company reported total income of Rs. 499.07 crores during the period ended September 30, 2024.

For the half year ended September 30, 2025, Rossari Biotech has reported total income of Rs. 113.26 crore as compared to Rs. 989.66 crores during the 6 Months period ended September 30, 2024.

Rossari Biotech has posted net profit of Rs. 70.47 crores for the 6 months period ended September 30, 2025 as against net profit of Rs.70.23 crores for the 6 months period ended September 30, 2024.

Rossari Biotech Limited

First Published : October 16, 2025 12:00 am